MTSR
Metsera, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +8.3% ·
share flow +18.9% ·
net new positions +7.7%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 13.89M | -11.8% | $726.97M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 2 | The Vanguard Group ✦ (passive) | 5.82M | +290.6% | $304.82M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (passive) | 3.84M | +210.0% | $200.70M | 0.0% | ▲ Add | 2 | SEC ↗ ×10 |
| 4 | Wellington Management ✦ | 3.66M | +6.8% | $191.50M | 0.0% | ▲ Add | 3 | SEC ↗ ×6 |
| 5 | State Street Global Advisors ✦ (passive) | 2.51M | +318.4% | $131.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 1.40M | +200.5% | $73.43M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | JPMorgan Chase ✦ | 650.36K | — | $34.03M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 8 | Goldman Sachs Group ✦ | 176.85K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 120.36K | New | $6.30M | 0.0% | New | 1 | SEC ↗ |
| 10 | Morgan Stanley ✦ | 92.94K | — | $4.86M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 11 | T. Rowe Price ✦ | 54.33K | -96.0% | $2.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 27.53K | -88.1% | $1.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 6.67K | New | $348,832 | 0.0% | New | 1 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Millennium Management | $6.30M | 0.0% |
| AQR Capital Management | $348,832 | 0.0% |
Exited
| Viking Global Investors | $45.99M | was 0.1% |
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.